FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Stitt

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Living Beings

Procedures

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
A K Berner; S Brockbank; O Brouwers; Michael Brownlee; L Colhoun; J W Curry; Ingeborg Klaassen; Carmel M McVicar; T Miyata; R Pringle; Casper G Schalkwijk; Reinier O Schlingemann; Alan Stitt
Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.
J Renwick Beattie; Manir Ali; Sorcha Finnegan; Ross W Hamilton; Paul M Hocking; Christopher F Inglehearn; John J McGarvey; Alan Stitt; William J Curry
Profiling retinal biochemistry in the MPDZ mutant retinal dysplasia and degeneration chick: a model of human RP and LCA.
J Renwick Beattie; Anna M Pawlak; John J McGarvey; Alan Stitt
Sclera as a surrogate marker for determining AGE-modifications in Bruch's membrane using a Raman spectroscopy-based index of aging.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Stitt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A K Berner; S Brockbank; O Brouwers; Michael Brownlee; L Colhoun; J W Curry; Ingeborg Klaassen; Carmel M McVicar; T Miyata; R Pringle; Casper G Schalkwijk; Reinier O Schlingemann; Alan Stitt
Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.
Diabetologia 2012;55(3):845-54.
2012: J Renwick Beattie; Manir Ali; Sorcha Finnegan; Ross W Hamilton; Paul M Hocking; Christopher F Inglehearn; John J McGarvey; Alan Stitt; William J Curry
Profiling retinal biochemistry in the MPDZ mutant retinal dysplasia and degeneration chick: a model of human RP and LCA.
Investigative ophthalmology & visual science 2012;53(1):413-20.
2011: J Renwick Beattie; Anna M Pawlak; John J McGarvey; Alan Stitt
Sclera as a surrogate marker for determining AGE-modifications in Bruch's membrane using a Raman spectroscopy-based index of aging.
Investigative ophthalmology & visual science 2011;52(3):1593-8.
2011: T M Curtis; R Hamilton; P-H Yong; Carmel M McVicar; A Berner; R Pringle; K Uchida; R Nagai; S Brockbank; Alan Stitt
Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products.
Diabetologia 2011;54(3):690-8.
2010: H Zong; M Ward; A Madden; P H Yong; G A Limb; T M Curtis; Alan Stitt
Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).
Diabetologia 2010;53(12):2656-66.
2010: J Renwick Beattie; Anna M Pawlak; Michael E Boulton; Jianye Zhang; Vincent M Monnier; John J McGarvey; Alan Stitt
Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(12):4816-24.
2010: Reinhold J Medina; Christina L O'Neill; Mervyn W Humphreys; Tom A Gardiner; Alan Stitt
Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy.
Investigative ophthalmology & visual science 2010;51(11):5906-13.
2010: Alan Stitt
AGEs and diabetic retinopathy.
Investigative ophthalmology & visual science 2010;51(10):4867-74.
2010: J O'Neill; A Czerwiec; I Agbaje; Josephine V Glenn; Alan Stitt; Neil McClure; Con Mallidis
Differences in mouse models of diabetes mellitus in studies of male reproduction.
International journal of andrology 2010;33(5):709-16.
2010: Carmel M McVicar; Liza M Colhoun; Jodie L Abrahams; Claire L Kitson; Ross Hamilton; Reinhold J Medina; Dash Durga; Tom A Gardiner; Pauline M Rudd; Alan Stitt
Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy.
PloS one 2010;5(7):e11870.
2010: Sorcha Finnegan; Joanne Robson; Paul M Hocking; Manir Ali; Chris F Inglehearn; Alan Stitt; William J Curry
Proteomic profiling of the retinal dysplasia and degeneration chick retina.
Molecular vision 2010;16():7-17.
2010: Louise McDonald; Graham R Lee; Tanyth E Degooyer; Denise McDonald; Paul Canning; Elizabeth J Kelso; Barbara J McDermott; Alan Stitt
Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy.
Ophthalmic research 2010;43(2):99-107.
2009: Ashay D Bhatwadekar; Josephine V Glenn; Tim M Curtis; Maria B Grant; Alan Stitt; Tom A Gardiner
Retinal endothelial cell apoptosis stimulates recruitment of endothelial progenitor cells.
Investigative ophthalmology & visual science 2009;50(10):4967-73.
2009: Josephine V Glenn; Alan Stitt
The role of advanced glycation end products in retinal ageing and disease.
Biochimica et biophysica acta 2009;1790(10):1109-16.
2009: Permal Deo; Josephine V Glenn; Lesley A Powell; Alan Stitt; Jennifer M Ames
Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated casein.
Journal of biochemical and molecular toxicology 2009;23(5):364-72.
2009: Con Mallidis; I M Agbaje; D A Rogers; Josephine V Glenn; R Pringle; Brew Atkinson; K Steger; Alan Stitt; Neil McClure
Advanced glycation end products accumulate in the reproductive tract of men with diabetes.
International journal of andrology 2009;32(4):295-305.
2009: Denise M McDonald; Gary Coleman; Ashay Bhatwadekar; Tom A Gardiner; Alan Stitt
Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction.
Molecular vision 2009;15():1509-20.
2009: Josephine V Glenn; Helen Mahaffy; Keqiang Wu; Gill Smith; Ryoji Nagai; David A C Simpson; Michael E Boulton; Alan Stitt
Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
Investigative ophthalmology & visual science 2009;50(1):441-51.
2008: X Zhang; Y Lai; David R McCance; K Uchida; D M McDonald; Tom A Gardiner; Alan Stitt; Tim M Curtis
Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.
Diabetologia 2008;51(9):1723-30.
2008: Anna M Pawlak; Josephine V Glenn; J Renwick Beattie; John J McGarvey; Alan Stitt
Advanced glycation as a basis for understanding retinal aging and noninvasive risk prediction.
Annals of the New York Academy of Sciences 2008;1126():59-65.
2008: A Bhatwadekar; Josephine V Glenn; J L Figarola; S Scott; Tom A Gardiner; S Rahbar; Alan Stitt
A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
The British journal of ophthalmology 2008;92(4):545-7.
2008: Ashay D Bhatwadekar; Josephine V Glenn; Gang Li; Tim M Curtis; Tom A Gardiner; Alan Stitt
Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy.
Investigative ophthalmology & visual science 2008;49(3):1232-41.
2008: Reinhold J Medina; Christina L O'Neill; Adrian B Devine; Tom A Gardiner; Alan Stitt
The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies.
PloS one 2008;3(7):e2584.
2007: Josephine V Glenn; J Renwick Beattie; Lindsay Barrett; Norma Frizzell; Suzanne R Thorpe; Mike E Boulton; John J McGarvey; Alan Stitt
Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(13):3542-52.
2007: Con Mallidis; Ishola Agbaje; Deirdre Rogers; Josephine Glenn; Stephen McCullough; Brew Atkinson; Klaus Steger; Alan Stitt; Neil McClure
Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus.
Human reproduction (Oxford, England) 2007;22(8):2169-77.
2007: John M Hughes; Esther J Kuiper; Ingeborg Klaassen; Paul Canning; Alan Stitt; Jan van Bezu; Casper G Schalkwijk; Cornelis J F Van Noorden; Reinier O Schlingemann
Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
Diabetologia 2007;50(5):1089-98.
2007: Gary Coleman; Tom A Gardiner; Ariel Boutaud; Alan Stitt
Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2007;245(4):581-7.
2007: Mary K McGahon; Jennine Dawicki; Aruna Arora; David A C Simpson; Tom A Gardiner; Alan Stitt; C Norman Scholfield; J Graham McGeown; Tim M Curtis
Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle.
American journal of physiology. Heart and circulatory physiology 2007;292(2):H1001-8.
2007: Paul Canning; Josephine V Glenn; Daniel K Hsu; Fu-Tong Liu; Tom A Gardiner; Alan Stitt
Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
Experimental diabetes research 2007;2007():51837.
2007: Tom A Gardiner; Desmond B Archer; Tim M Curtis; Alan Stitt
Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis.
Microcirculation (New York, N.Y. : 1994) 2007;14(1):25-38.
2006: Matthew Campbell; Ross Collery; Alice McEvoy; Tom A Gardiner; Alan Stitt; Brenda Brankin
Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Current eye research 2006;31(12):1033-45.
2006: Tanyth E De Gooyer; Kathryn A Stevenson; Peter Humphries; David A C Simpson; Tom A Gardiner; Alan Stitt
Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.
Investigative ophthalmology & visual science 2006;47(12):5561-8.
2006: Tanyth E De Gooyer; Kathryn A Stevenson; Peter Humphries; David A C Simpson; Tim M Curtis; Tom A Gardiner; Alan Stitt
Rod photoreceptor loss in Rho-/- mice reduces retinal hypoxia and hypoxia-regulated gene expression.
Investigative ophthalmology & visual science 2006;47(12):5553-60.
2005: R Kane; L Stevenson; C Godson; Alan Stitt; C O'Brien
Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose.
The British journal of ophthalmology 2005;89(12):1638-42.
2005: Denys N Wheatley; Ruth Kilfeather; Alan Stitt; Elaine Campbell
Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines.
Cancer letters 2005;227(2):141-52.
2005: Brenda Brankin; Matthew Campbell; Paul Canning; Tom A Gardiner; Alan Stitt
Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Experimental eye research 2005;81(1):22-31.
2005: Alan Stitt
The maillard reaction in eye diseases.
Annals of the New York Academy of Sciences 2005;1043():582-97.
2005: Alan Stitt; Ciara McGoldrick; Aine Rice-McCaldin; David R McCance; Josephine V Glenn; Daniel K Hsu; Fu-Tong Liu; Suzanne R Thorpe; Tom A Gardiner
Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3.
Diabetes 2005;54(3):785-94.
2005: Tom A Gardiner; David Gibson; Tanyth E De Gooyer; Vidal de la Cruz; Denise M McDonald; Alan Stitt
Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
The American journal of pathology 2005;166(2):637-44.
2005: Alan Stitt; Tim M Curtis
Advanced glycation and retinal pathology during diabetes.
Pharmacological reports : PR 2005;57 Suppl():156-68.
2005: S McFarlane; Josephine V Glenn; Agnieszka M Lichanska; David A C Simpson; Alan Stitt
Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium.
The British journal of ophthalmology 2005;89(1):107-12.
2004: Sarah-Jane Hughes; Noreen Wall; C Norman Scholfield; J Graham McGeown; Tom A Gardiner; Alan Stitt; Tim M Curtis
Advanced glycation endproduct modified basement membrane attenuates endothelin-1 induced [Ca2+]i signalling and contraction in retinal microvascular pericytes.
Molecular vision 2004;10():996-1004.
2004: Alan Stitt; S-J Hughes; Paul Canning; O Lynch; O Cox; Norma Frizzell; Suzanne R Thorpe; T G Cotter; Tim M Curtis; Tom A Gardiner
Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor.
Diabetologia 2004;47(10):1735-46.
2004: Nathan L Alderson; Mark E Chachich; Norma Frizzell; Paul Canning; Tom Metz; Andrzej Januszewski; N N Youssef; Alan Stitt; John W Baynes; Suzanne R Thorpe
Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.
Diabetologia 2004;47(8):1385-95.
2004: Alan Stitt; Donna Graham; Tom A Gardiner
Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
Molecular vision 2004;10():432-8.
2004: G J Mahon; H R Anderson; Tom A Gardiner; S McFarlane; D B Archer; Alan Stitt
Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy.
Current eye research 2004;28(4):277-84.
2004: Jennifer L Wilkinson-Berka; Sanja Babic; Tanyth E De Gooyer; Alan Stitt; Kassie Jaworski; Leslie G T Ong; Darren J Kelly; Richard E Gilbert
Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy.
The American journal of pathology 2004;164(4):1263-73.
2004: Alan Stitt; Norma Frizzell; Suzanne R Thorpe
Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.
Current pharmaceutical design 2004;10(27):3349-60.
2003: Orla T Cox; David A C Simpson; Alan Stitt; Tom A Gardiner
Sources of PDGF expression in murine retina and the effect of short-term diabetes.
Molecular vision 2003;9():665-72.
2003: Tom A Gardiner; H R Anderson; Alan Stitt
Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
The Journal of pathology 2003;201(2):328-33.
2003: Tara C B Moore; Jonathan E Moore; Yuichi Kaji; Norma Frizzell; Tomohiko Usui; Vassiliki Poulaki; Iain L Campbell; Alan Stitt; Tom A Gardiner; Desmond B Archer; Anthony P Adamis
The role of advanced glycation end products in retinal microvascular leukostasis.
Investigative ophthalmology & visual science 2003;44(10):4457-64.
2003: Tom A Gardiner; H R Anderson; Thorsten P Degenhardt; Suzanne R Thorpe; John W Baynes; Desmond B Archer; Alan Stitt
Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.
Diabetologia 2003;46(9):1269-75.
2003: Alan Stitt
The role of advanced glycation in the pathogenesis of diabetic retinopathy.
Experimental and molecular pathology 2003;75(1):95-108.
2003: William J Curry; Anna Patricia McCollum; Simon Brockbank; Tom A Gardiner; Aaron G Maule; Alan Stitt
Characterisation of WE-14 in porcine ocular tissue.
Regulatory peptides 2003;113(1-3):41-7.
2003: Susan A Feeney; David A C Simpson; Tom A Gardiner; Cliona Boyle; Pamela Jamison; Alan Stitt
Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.
Investigative ophthalmology & visual science 2003;44(2):839-47.
2002: Alan Stitt; Alicia J Jenkins; Mark E Cooper
Advanced glycation end products and diabetic complications.
Expert opinion on investigational drugs 2002;11(9):1205-23.
2002: Alan Stitt; Tom A Gardiner; Nathan L Alderson; Paul Canning; Norma Frizzell; Noel Duffy; Cliona Boyle; Andrzej Januszewski; Mark E Chachich; John W Baynes; Suzanne R Thorpe; Nathan L Anderson
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.
Diabetes 2002;51(9):2826-32.
2002: Niamh McNally; Paul F Kenna; Derrick Rancourt; Tanweer Ahmed; Alan Stitt; William H Colledge; David Lloyd; Arpad Palfi; Brian O'Neill; Marian Humphries; Peter Humphries; G Jane Farrar
Murine model of autosomal dominant retinitis pigmentosa generated by targeted deletion at codon 307 of the rds-peripherin gene.
Human molecular genetics 2002;11(9):1005-16.
2002: Alan Stitt; Tom A Gardiner
Anti-angiogenic therapy for uveal melanoma--more haste, less speed.
The British journal of ophthalmology 2002;86(4):368-9.
2002: Avril Kennan; Aileen Aherne; Arpad Palfi; Marian Humphries; Alex McKee; Alan Stitt; David A C Simpson; Karin Demtroder; Torben F Orntoft; Carmen Ayuso; Paul F Kenna; G Jane Farrar; Peter Humphries
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice.
Human molecular genetics 2002;11(5):547-57.
2002: Dorota Gebarowska; Alan Stitt; Tom A Gardiner; Patrick Harriott; Brett Greer; John Nelson
Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularization.
The American journal of pathology 2002;160(1):307-13.
2001: DJ McKenna; David A C Simpson; Susan A Feeney; Tom A Gardiner; Cliona Boyle; J Nelson; Alan Stitt
Expression of the 67 kDa laminin receptor (67LR) during retinal development: correlations with angiogenesis.
Experimental eye research 2001;73(1):81-92.
2001: Alan Stitt
Advanced glycation: an important pathological event in diabetic and age related ocular disease.
The British journal of ophthalmology 2001;85(6):746-53.
2001: DJ McKenna; J Nelson; Alan Stitt
Advanced glycation alters expression of the 67kDa laminin receptor in retinal microvascular endothelial cells.
Life sciences 2001;68(24):2695-703.
2000: Alan Stitt; G A Burke; F Chen; C B T McMullen; H Vlassara
Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(15):2390-2.
2000: CJ He; F Zheng; Alan Stitt; Liliane J Striker; M Hattori; Helen Vlassara
Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.
Kidney international 2000;58(5):1931-40.
2000: David A C Simpson; Susan A Feeney; Cliona Boyle; Alan Stitt
Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR.
Molecular vision 2000;6():178-83.
2000: Alan Stitt; T Bhaduri; C B T McMullen; Tom A Gardiner; Desmond B Archer
Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats.
Molecular cell biology research communications : MCBRC 2000;3(6):380-8.
2000: E A Donaldson; DJ McKenna; C B T McMullen; William N Scott; Alan Stitt; J Nelson
The expression of membrane-associated 67-kDa laminin receptor (67LR) is modulated in vitro by cell-contact inhibition.
Molecular cell biology research communications : MCBRC 2000;3(1):53-9.
1999: David A C Simpson; G M Murphy; T Bhaduri; Tom A Gardiner; Desmond B Archer; Alan Stitt
Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia.
Biochemical and biophysical research communications 1999;262(2):333-40.
1999: Alan Stitt; C He; H Vlassara
Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
Biochemical and biophysical research communications 1999;256(3):549-56.
1998: Alan Stitt; J E Moore; J A Sharkey; G Murphy; David A C Simpson; Richard Bucala; H Vlassara; Desmond B Archer
Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
Investigative ophthalmology & visual science 1998;39(13):2517-23.
1998: Alan Stitt; David A C Simpson; C Boocock; Tom A Gardiner; G M Murphy; Desmond B Archer
Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
The Journal of pathology 1998;186(3):306-12.
1998: I D Nicholl; Alan Stitt; J E Moore; A J Ritchie; Desmond B Archer; Richard Bucala
Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.
Molecular medicine (Cambridge, Mass.) 1998;4(9):594-601.
1998: Usha Chakravarthy; R G Hayes; Alan Stitt; E McAuley; D B Archer
Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
Diabetes 1998;47(6):945-52.
1998: Alan Stitt; D McKenna; David A C Simpson; Tom A Gardiner; Patrick Harriott; Desmond B Archer; J Nelson
The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
The American journal of pathology 1998;152(5):1359-65.
1997: Usha Chakravarthy; R G Hayes; Alan Stitt; A Douglas
Endothelin expression in ocular tissues of diabetic and insulin-treated rats.
Investigative ophthalmology & visual science 1997;38(10):2144-51.
1997: Alan Stitt; C He; S Friedman; Larry A Scher; P Rossi; L Ong; HW Founds; YM Li; Richard Bucala; H Vlassara
Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.
Molecular medicine (Cambridge, Mass.) 1997;3(9):617-27.
1997: Alan Stitt; Richard Bucala; H Vlassara
Atherogenesis and advanced glycation: promotion, progression, and prevention.
Annals of the New York Academy of Sciences 1997;811():115-27; discussion 127-9.
1997: Alan Stitt; YM Li; Tom A Gardiner; Richard Bucala; Desmond B Archer; H Vlassara
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
The American journal of pathology 1997;150(2):523-31.
1996: YM Li; T Mitsuhashi; D Wojciechowicz; N Shimizu; J Li; Alan Stitt; C He; D Banerjee; H Vlassara
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(20):11047-52.
1996: Alan Stitt; Tom A Gardiner; D B Archer
Retinal and choroidal response to panretinal photocoagulation and ultrastructural perspective.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1996;234(5):349.
1996: Alan Stitt; Ian Fairweather
Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.
Parasitology research 1996;82(4):333-9.
1996: Alan Stitt; Usha Chakravarthy; Tom A Gardiner; Desmond B Archer
Endothelin-like immunoreactivity and receptor binding in the choroid and retina.
Current eye research 1996;15(1):111-7.
1995: H R Anderson; Alan Stitt; Tom A Gardiner; Desmond B Archer
Diabetic retinopathy: morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments.
The British journal of ophthalmology 1995;79(12):1120-3.
1995: Alan Stitt; Usha Chakravarthy; Desmond B Archer; Tom A Gardiner
Increased endocytosis in retinal vascular endothelial cells grown in high glucose medium is modulated by inhibitors of nonenzymatic glycosylation.
Diabetologia 1995;38(11):1271-5.
1995: Alan Stitt; Tom A Gardiner; Desmond B Archer
Retinal and choroidal responses to panretinal photocoagulation: an ultrastructural perspective.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1995;233(11):699-705.
1995: Alan Stitt; Tom A Gardiner; Desmond B Archer
Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients.
The British journal of ophthalmology 1995;79(4):362-7.
1995: Tom A Gardiner; Alan Stitt; Desmond B Archer
Retinal vascular endothelial cell endocytosis increases in early diabetes.
Laboratory investigation; a journal of technical methods and pathology 1995;72(4):439-44.
1995: Alan Stitt; Ian Fairweather; R O Mackender
The effect of triclabendazole ("Fasinex") on protein synthesis by the liver fluke, Fasciola hepatica.
International journal for parasitology 1995;25(4):421-9.
1995: Usha Chakravarthy; Alan Stitt; J McNally; J R Bailie; E M Hoey; P Duprex
Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes.
Current eye research 1995;14(4):285-94.
1994: H R Anderson; Alan Stitt; Tom A Gardiner; Desmond B Archer
Stereological estimation of Weibel-Palade bodies in the retinal vasculature of normal and diabetic dogs.
Current eye research 1994;13(9):705-10.
1994: Alan Stitt; H R Anderson; Tom A Gardiner; J R Bailie; Desmond B Archer
Receptor-mediated endocytosis and intracellular trafficking of insulin and low-density lipoprotein by retinal vascular endothelial cells.
Investigative ophthalmology & visual science 1994;35(9):3384-92.
1994: H R Anderson; Alan Stitt; Tom A Gardiner; D B Archer
Estimation of the surface area and volume of the retinal capillary basement membrane using the stereologic method of vertical sections.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1994;16(4):253-60.
1994: Alan Stitt; Ian Fairweather
The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
Parasitology 1994;108 ( Pt 5)():555-67.
1994: Alan Stitt; H R Anderson; Tom A Gardiner; Desmond B Archer
Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments.
The British journal of ophthalmology 1994;78(2):133-7.
1994: Alan Stitt; H R Anderson; Tom A Gardiner; I McIntyre; Desmond B Archer
The combined effects of diabetes and ionising radiation on the rat retina: an ultrastructural study.
Current eye research 1994;13(1):79-86.
1994: Tom A Gardiner; Alan Stitt; H R Anderson; Desmond B Archer
Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs.
The British journal of ophthalmology 1994;78(1):54-60.
1993: Alan Stitt; Ian Fairweather
Fasciola hepatica: the effect of the microtubule inhibitors colchicine and tubulozole-C on the ultrastructure of the adult fluke.
Parasitology 1993;107 ( Pt 3)():297-309.
1993: H R Anderson; Alan Stitt; Tom A Gardiner; S J Lloyd; Desmond B Archer
Induction of alloxan/streptozotocin diabetes in dogs: a revised experimental technique.
Laboratory animals 1993;27(3):281-5.
1993: Alan Stitt; Ian Fairweather
Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
Parasitology research 1993;79(7):529-36.
1992: Alan Stitt; Ian Fairweather; A G Trudgett; C F Johnston; S M Anderson
Localisation of actin in the liver fluke, Fasciola hepatica.
Parasitology research 1992;78(2):96-102.
1992: Alan Stitt; Ian Fairweather; A G Trudgett; C F Johnston
Fasciola hepatica: localization and partial characterization of tubulin.
Parasitology research 1992;78(2):103-7.
1991: Alan Stitt; Ian Fairweather; C F Johnston
Fasciola hepatica: disruption of spermatogenesis by the microfilament inhibitor cytochalasin B.
Parasitology research 1991;77(2):123-8.
1991: Alan Stitt; Ian Fairweather
Fasciola hepatica: the effect of the microfilament inhibitor cytochalasin B on the ultrastructure of the adult fluke.
Parasitology research 1991;77(8):675-85.
1990: Alan Stitt; Ian Fairweather
Spermatogenesis and the fine structure of the mature spermatozoon of the liver fluke, Fasciola hepatica (Trematoda: Digenea).
Parasitology 1990;101 Pt 3():395-407.